At the heart of P³ lies a smartphone-based platform that leverages both brief, engaging gamified tasks and passive sensing technologies to create a detailed profile of an individual’s brain function, specifically in how it handles prediction errors. Prediction error is a fundamental concept in neuroscience, referring to the brain’s continuous effort to anticipate sensory inputs and outcomes, adjusting its internal models when discrepancies arise. By capturing these nuances, P³ goes beyond traditional psychiatric categories, proposing four transdiagnostic domains to characterize mental functioning: interoceptive, exteroceptive, action-outcome, and social.

Each of these domains represents a different dimension of how individuals process information and experiences. Interoceptive precision relates to the brain’s interpretation of internal bodily signals, while exteroceptive precision concerns its processing of external sensory stimuli. Action-outcome precision reflects the expectations about the results of one’s actions, and social precision encapsulates the processing of social cues and interactions. Through dynamic assessment, the P³ framework categorizes each domain as hyper-precise, hypo-precise, or flexible—terms that describe the rigidity or adaptability of one’s internal predictive models.

Hyper-precise profiles denote an overly rigid adherence to prior beliefs, which may resist updating even when faced with new evidence, leading to distorted perceptions or behaviors. Conversely, hypo-precision indicates excessive sensitivity to incoming data, causing a person’s brain to overreact or be destabilized by environmental changes. Flexible precision embodies a balanced system capable of adapting appropriately, effectively integrating prior expectations with new information.

A compelling aspect of the P³ model is its on-device artificial intelligence agent designed to maintain user privacy while continuously updating the precision profile based on ongoing data collection. This AI adapts the personal model over time, learning from fluctuations in the individual’s cognitive and behavioral patterns, thus fostering a learning health system that personalizes treatment and tracks progress. Subtle, targeted micro-interventions could be deployed intelligently when predicted benefits are high, avoiding over-treatment or unnecessary interventions.

What truly sets P³ apart is its potential to redefine psychiatric nosology by offering a mechanistic vocabulary that transcends symptom overlap. This enables clinicians to discern the underlying cognitive and neural processes driving mental health challenges rather than merely documenting surface features. For instance, two patients diagnosed with depression could have markedly different precision profiles—one exhibiting hyper-precise action-outcome processing while the other shows hypo-precise social predictions—thereby necessitating fundamentally different therapeutic approaches tailored to those specific dysfunctions.

Such a paradigm shift is poised to address many of the challenges facing mental health care, notably the notorious heterogeneity and comorbidity that blur diagnostic categories and complicate treatment decisions. By capturing the ‘precision signature’ of an individual across multiple domains, P³ endeavors to move precision psychiatry forward from theoretical ambition into practical reality.

The envisaged gamified tasks incorporated into the smartphone application are more than just engaging tools—they function as finely tuned probes into cognitive functions. These brief, enjoyable activities gently assess an individual’s response to various stimuli and scenarios, offering insights into how their brain predicts and adapts in different contexts. Supplemented by passive sensing—which might include monitoring movement patterns, sleep, or physiological signals—the system continuously aggregates data without burdening the user.

From a neuroscientific perspective, this approach is deeply rooted in predictive coding theories that describe perception and action as driven by hierarchical Bayesian inference. Here, the brain constructs and updates internal models of the world by constantly predicting sensory input and minimizing the difference between expectation and reality. Abnormalities in precision weighting at different hierarchical levels may underpin various psychiatric symptoms, ranging from anxiety to psychosis, thus unifying disparate conditions through shared computational mechanisms.

Importantly, P³ acknowledges the centrality of functional outcomes and quality of life in evaluating interventions, instead of relying solely on symptom severity or distress. This emphasis aligns with a growing consensus that meaningful recovery in psychiatry is best gauged by improvements in everyday functioning, social engagement, and well-being, marking a human-centered shift in clinical priorities.

The potential for P³ to serve as a scalable, rigorous, and clinically relevant tool resonates with the broader movement toward digital psychiatry and personalized medicine. By embedding this sophisticated computational framework within accessible smartphone technology, it lowers barriers to widespread implementation and real-time monitoring. Patients can benefit from ongoing support tailored to their evolving profiles, while clinicians gain actionable insights beyond conventional diagnostic labels.

Future research trajectories will likely focus on refining the gamified tasks, validating predictive models against longitudinal clinical outcomes, and integrating multimodal data streams for richer, multidimensional profiling. Ethical considerations—especially regarding data privacy, consent, and algorithmic transparency—will be paramount as P³ transitions from concept to clinical application, ensuring trust and safeguarding patient rights.

In summary, Precision Predictive Priors represents a bold, interdisciplinary fusion of computational neuroscience, clinical psychiatry, and digital innovation. By capturing the intricacies of individual brain prediction mechanisms across key psychological domains, this framework promises a new era of truly precision-guided mental health care. Its vision goes beyond mere symptom management, aspiring to foster adaptive brain function and resilient mental health through personalized, contextually informed interventions.

As psychiatry grapples with the complexities of mental illnesses that defy neat classification, P³ offers a beacon of clarity rooted in brain-based mechanisms. Its smart integration of technology and theory not only enriches our understanding of mental health disorders but also empowers patients and clinicians alike with novel pathways toward healing and well-being. This emerging framework, articulated by Lyndon in the forthcoming 2026 edition of Nature Mental Health, stands poised to redefine the future of psychiatric diagnosis and treatment with remarkable precision and humanity.

Subject of Research: Precision psychiatry through computational neuroscience focusing on brain prediction error management and dynamic precision profiling.

Article Title: From symptoms to signatures: a transdiagnostic predictive coding framework for precision psychiatry.

Article References:
Lyndon, S. From symptoms to signatures: a transdiagnostic predictive coding framework for precision psychiatry. Nat. Mental Health (2026). https://doi.org/10.1038/s44220-026-00607-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s44220-026-00607-7

Hallucinations—perceptions without external stimuli—are a hallmark of multiple mental health disorders, most notably schizophrenia. Traditional models have struggled to provide a comprehensive mechanistic framework that encapsulates the multifaceted nature of these experiences. Buck and colleagues identify the primary limitations in current theories that either oversimplify the neural circuits involved or fail to adequately translate findings from animal models to human subjects. Their study methodically refines these mechanistic models, introducing nuanced variables that mirror real-world clinical presentations more precisely.

Central to their approach is the integration of predictive coding frameworks with neurobiological data. Predictive coding posits that the brain continuously creates and updates a mental model of the environment by processing sensory input against prior expectations. Hallucinations, within this context, may arise from aberrant inference processes where the brain erroneously predicts sensory data, leading to false perceptual experiences. Buck et al. delve into the neurochemical and circuit-level substrates that could disrupt these predictive processes, placing emphasis on dysregulated dopaminergic signaling and cortical-thalamic connectivity.

Their model innovatively incorporates a multi-layered neural architecture where hierarchical processing deficits coexist with local circuit dysfunctions. This dynamic interplay reflects how hallucinations might manifest heterogeneously across patients and clinical contexts. Crucially, the model accommodates individual variability by factoring in genetic predispositions, environmental triggers, and neurodevelopmental trajectories, thereby enhancing its translatability to real-world clinical scenarios.

Another remarkable facet of their work is the application of advanced computational simulations. These simulations allow testing of how specific neural alterations yield distinct hallucinatory patterns, offering predictive power that can be empirically validated through neuroimaging and electrophysiological studies. This methodological synergy not only illuminates possible causal pathways but also informs targeted therapeutic interventions, such as neuromodulation and precision pharmacology.

Beyond theoretical rigor, this research is poised to revolutionize early diagnosis and intervention. By identifying biomarkers that correspond with model parameters predictive of hallucination onset and severity, clinicians could tailor interventions with unprecedented accuracy. Early-stage psychosis, often marked by subtle hallucinatory experiences, could be intercepted more effectively, potentially altering disease trajectories and improving patient outcomes.

Moreover, the refined mechanistic framework sheds light on the heterogeneity within hallucinations themselves. Distinctions between auditory, visual, and multimodal hallucinations are mapped onto differing network dysfunctions, suggesting that standardized treatment approaches might be suboptimal. Personalized treatment strategies, informed by mechanistic insights, stand to become the new standard in psychiatric care, enhancing efficacy and minimizing side effects.

The implications extend beyond schizophrenia. Hallucinations occur in diverse contexts, such as Parkinson’s disease, dementia, and even in healthy individuals under sensory deprivation. By capturing common mechanistic threads alongside disorder-specific nuances, the model provides a unifying framework adaptable across conditions. This breadth increases its translational potential, fostering interdisciplinary collaborations among neurologists, psychiatrists, and computational neuroscientists.

Buck and colleagues also confront the challenge of cross-species translation head-on. Animal models, indispensable for mechanistic exploration, often fail to capture the subjective aspects of hallucinations. Their refined models incorporate behavioral proxies and neural markers that better align animal data with human phenomenology. This approach could accelerate preclinical testing pipelines, speeding up the development of novel therapeutics.

Central to this research’s potential impact is its methodological transparency and open-science ethos. Accompanying the publication are open-source computational tools and datasets, empowering research groups worldwide to replicate, challenge, and extend the findings. This community-driven approach fosters cumulative knowledge-building and reduces duplicative efforts, accelerating progress in understanding and treating hallucinations.

Ethical considerations are thoughtfully embedded in their framework. By providing clearer mechanistic targets, the risk of stigmatizing individuals experiencing hallucinations diminishes. Instead, it repositions hallucinations not as mere symptoms of pathology, but as phenomena rooted in identifiable neurobiological processes—a shift that could transform societal attitudes and reduce psychiatric stigma.

In summary, this seminal study by Buck, Iigaya, and Horga signifies a major leap towards mechanistically grounded, clinically translatable models of hallucinations. Their work integrates predictive coding, neurobiology, computational modeling, and clinical data to create a robust framework that holds promise for illuminating the complex neuropsychiatric phenomena of hallucinations. As the field moves towards precision psychiatry, such refined models are indispensable in translating neurobiological insights into tangible therapeutic advances.

The future of hallucination research, as charted by this study, is both ambitious and hopeful. It invites an era where mental health disorders are understood through the lens of neural computation and actionable biology. This evolution heralds new possibilities for patient care, scientific innovation, and societal perceptions—redefining hallucinations from enigmatic symptoms to comprehensible mechanistic phenomena with clear paths toward intervention.

Subject of Research: Mechanistic models of hallucinations and their translatability in neuropsychiatric research.

Article Title: Refining mechanistic models of hallucinations for enhanced translatability.

Article References:
Buck, J., Iigaya, K. & Horga, G. Refining mechanistic models of hallucinations for enhanced translatability. Transl Psychiatry (2025). https://doi.org/10.1038/s41398-025-03773-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-025-03773-x